Monday, March 19, 2012

NVS - Adjustment

The following adjustment was made today on Novartis (NVS). All prices include IB commissions.

CriteriaValue
Dividend Champions StatusContender
Years of Consecutive Dividend Increases10
Fair Value Estimate$71.00
Target Buy Price$56.80
Target Margin of Safety20.00%
Actual Buy Price$55.00
Actual Margin of Safety20.29%

DateStockDescriptionTransactionStatusStock InvestmentIncome Generated
3/19/2012NVSContinued TradeSTO 1 May12 57.50 Call @ 0.59  $58.97

Current Position Summary

Cost Basis($5,500.00)
Income Generated$137.94
Percent Income Generated2.51%
Annualized Income Generated10.64%
Net Profit If Assigned$387.94
Percent Return If Assigned7.05%
Annualized Return If Assigned29.94%
Days Held to Expiration86 days

Trade History

DateStockDescriptionTransactionStatusStock InvestmentIncome Generated
2/22/2012NVSCSP Margin UsedCSP 100 NVS @ 55.00 ($5,500.00) 
2/22/2012NVSInitial Put OptionSTO 1 Mar12 55.00 Put @ 0.79Exercised $78.97
3/16/2012NVSCSP Margin ReturnedCSP 100 NVS @ -55.00 $5,500.00 
3/16/2012NVSStock AssignedEX 1 Mar12 55.00 Put @ -55.00 ($5,500.00) 
3/19/2012NVSContinued TradeSTO 1 May12 57.50 Call @ 0.59  $58.97
5/18/2012NVS Totals ($5,500.00)$137.94
DTE86 Percent Income/Annualized 2.51%10.64%